The Institut Pasteur de Lille is currently testing a potentially active molecule against Covid-19. This is an already existing antibiotic, clofoctol. A clinical trial will be launched on more than 600 patients, and a first analysis of the results is expected around September 15.
The Institut Pasteur de Lille is currently testing a potentially active molecule against Covid-19.
This is an already existing antibiotic, clofoctol.
A clinical trial will be launched on more than 600 patients, and a first analysis of the results is expected around September 15.